150 related articles for article (PubMed ID: 9438357)
41. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
Hindler JA; Bruckner DA
J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458
[TBL] [Abstract][Full Text] [Related]
42. A comparison of the myocardial depressant effects of several aminoglycoside antibiotics.
Descotes J; Ollagnier M; Lievre M; Evreux JC
Chemotherapy; 1981; 27(2):89-94. PubMed ID: 6907078
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
44. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
45. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
Adwan K; Abu-Hasan N; Al-Asmar H
J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
[TBL] [Abstract][Full Text] [Related]
46. Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.
Anderson SE; Sherman EX; Weiss DS; Rather PN
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111627
[TBL] [Abstract][Full Text] [Related]
47. L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Valiant ME; Gilfillan EC; Gadebusch HH; Pelak BA
J Antibiot (Tokyo); 1989 May; 42(5):807-14. PubMed ID: 2498278
[TBL] [Abstract][Full Text] [Related]
48. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
Viotte G; Olier B; Morin JP; Godin M
Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850
[TBL] [Abstract][Full Text] [Related]
49. Microbiological considerations in the use of tobramycin and related aminoglycosidic aminocyclitol antibiotics.
Moellering RC
Med J Aust; 1977 Oct; 2(3 Pt 1 Suppl):4-8. PubMed ID: 600197
[No Abstract] [Full Text] [Related]
50. Comparative in vitro studies with netilmicin, amikacin, gentamicin, sissomicin and tobramycin.
Habwe V; Shadomy S
J Antimicrob Chemother; 1979 Jan; 5(1):73-9. PubMed ID: 762007
[No Abstract] [Full Text] [Related]
51. Effects of combinations of clindamycin with gentamicin, tobramycin, and amikacin against Staphylococcus aureus.
Watanakunakorn C; Glotzbecker C
J Antimicrob Chemother; 1980 Nov; 6(6):785-91. PubMed ID: 7440469
[No Abstract] [Full Text] [Related]
52. Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
Elliott AM; Karam GH; Cobbs CG
Antimicrob Agents Chemother; 1983 Dec; 24(6):847-50. PubMed ID: 6318661
[TBL] [Abstract][Full Text] [Related]
53. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
Moellering RC; Wennersten C; Kunz LJ; Poitras JW
Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
[TBL] [Abstract][Full Text] [Related]
54. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
[TBL] [Abstract][Full Text] [Related]
55.
Fleischmann WA; Greenwood-Quaintance KE; Patel R
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712206
[TBL] [Abstract][Full Text] [Related]
56. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
Ximenes J; Hirai CK; Takenaka IM
J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
[TBL] [Abstract][Full Text] [Related]
57. Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.
Majtán V; Majtánová L
Folia Microbiol (Praha); 1997; 42(4):327-32. PubMed ID: 9449780
[TBL] [Abstract][Full Text] [Related]
58. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Majtán V; Hostacká A
Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
[TBL] [Abstract][Full Text] [Related]
59. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
Eickhoff TC; Ehret JM
Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
[TBL] [Abstract][Full Text] [Related]
60. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
